America Makes, the National Additive Manufacturing Innovation Institute, is proud to announce its plans to open its first America Makes Satellite Center on the campus of the institute's platinum-level member, The University of Texas at El Paso (UTEP), in conjunction with UTEP's renowned W.M. Keck Center for 3-D Innovation.
A patient has become the first to receive a new 'resistance-busting' experimental skin cancer drug with the launch of a phase I clinical trial. The patient has received a new panRAF inhibitor -- a new type of drug under development to address the problem of drug resistance in advanced skin cancer and a number of other cancer types.
A team of Empa scientists has, together with industrial partners, developed a novel chest strap device for the long-term monitoring of patients with heart and circulatory problems. What is special about the new system is that it records an electrocardiogram of the wearer. It is also self-moistening, which is essential for reliable signal monitoring. At the specialist exhibition, Techtextil, held recently in Frankfurt am Main, Germany, the system won the Techtextil Innovation Award 2015.
The open-access Journal of Health, Population and Nutrition is now being published by BioMed Central. The journal was first published in 1983 and in transferring to the open-access publisher it joins the growing number of global health journals within the portfolio.
The Children's Hospital of Eastern Ontario, the Ottawa Hospital, the University of Ottawa and McMaster University congratulate its researchers on forming Turnstone Biologics Inc., a biotechnology company focused on developing new treatments for cancer that harness the patient's own immune system.
Space-based radar technology could be harnessed by the renewable energy sector to drive down costs, according to academics at the University of Strathclyde.
BGI, the world's largest genomics organization, announced to expand relationship with QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) and to provide QIAGEN's Ingenuity Variant Analysis in integrated bioinformatics for all customers of BGI's sequencing services.
Pacific Biosciences of California Inc. today announced that BGI, the world's largest genomics organization, has purchased its first PacBio RS II instrument and plans to purchase additional units in order to integrate Single Molecule, Real-Time Sequencing into its global service business.
The University of Texas at Arlington announces a new partnership with a longtime Silicon Valley entrepreneur and alumna who will establish a strategic outpost to match technology developed within the University with investors and corporate partners.
This weekend a group of teenagers will test an 'artificial pancreas' in a real-world environment. Although Yale has been studying these devices for the last decade, this is the first time one will be tested in pediatric patients here outside the hospital.